NLM Logo

14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene MeSH Supplementary Concept Data 2023


MeSH Supplementary
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
Unique ID
C570909
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C570909
Entry Term(s)
SB1317
TG02
Registry Number
0
Heading Mapped to
*Heterocyclic Compounds, 4 or More Rings
Frequency
15
Note
has antineoplastic activity; also inhibits Fms-like tyrosine kinase-3; structure in first source
Source
J Med Chem. 2012 Jan 12;55(1):169-96.
Indexing Information
Cyclin-Dependent Kinases
Janus Kinase 2
Date of Entry
2012/03/24
Revision Date
2012/03/29
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene Preferred
TG02 Narrower
SB1317 Narrower
page delivered in 0.006s